Hyman Lab: Bradley Hyman, MD, PhD
Contact Information
MassGeneral Institute for Neurodegenerative Disease (MIND)
Building 114, Charlestown Navy Yard
114 16th Street, Room 2003
Mailcode: CNY B114-2-2003
Charlestown,
MA
02129
Phone: 855-644-6387
Fax: 617-724-1480
Explore This Lab
Overview
Dr. Hyman directs the Alzheimer’s disease research unit at the MassGeneral Institute for Neurodegenerative Disease (MIND) with the goal of understanding the neuropathophysiologic and genetic factors that underlie dementia. His laboratory studies the anatomical and molecular basis of dementia in Alzheimer’s disease, and dementia with Lewy bodies.
Dr. Hyman’s research includes collaborations with several labs working on different aspects of neurodegenerative disease and dementia.
Research Positions
All applicants should register with the Mass General Careers website.
Read about and apply for residency, fellowship and observership programs in neurology.
Selected Publications
Hyman BT, Yuan J. Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology. Nat Rev Neurosci. 2012; 13(6):395-406. View in: PubMed
Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kövari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012 May; 71(5):362-81. View in: PubMed
Wu HY, Hudry E, Hashimoto T, Uemura K, Fan ZY, Berezovska O, Grosskreutz CL, Bacskai BJ, Hyman BT. Distinct Dendritic Spine and Nuclear Phases of Calcineurin Activation after Exposure to Amyloid-ß Revealed by a Novel Fluorescence Resonance Energy Transfer Assay. J Neurosci. 2012 Apr 11; 32(15):5298-309. View in: PubMed
Pankratz N, Beecham GW, Destefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T. Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2. Ann Neurol. 2012 Mar; 71(3):370-84. View in: PubMed
Hudry E, Wu HY, Arbel-Ornath M, Hashimoto T, Matsouaka R, Fan Z, Spires-Jones TL, Betensky RA, Bacskai BJ, Hyman BT. Inhibition of the NFAT pathway alleviates amyloid Beta neurotoxicity in a mouse model of Alzheimer's disease. J Neurosci. 2012 Feb 29; 32(9):3176-92. View in: PubMed
Our Research Team
-
- Director, Massachusetts Alzheimer Disease Research Center
Neurology Research at Mass General
Explore current research projects in the Department of Neurology or search our open clinical trials and medical research studies.